BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.01 (+25.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Total Current Liabilities (2017 - 2026)

Updated

BioXcel Therapeutics (BTAIQ) recorded Total Current Liabilities of $137.15 million in Q2 2026, up 310.9% from $33.38 million a year earlier and up 149.4% from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, BioXcel Therapeutics reported Total Current Liabilities of $53.93 million, up 142.5% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 35.4% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $22.23 million in FY2024 (-18.5%), $27.27 million in FY2023 (-17.1%), $32.9 million in FY2022 (+97.4%) and $16.67 million in FY2021 (+40.7%).
  • The Q2 2026 figure is the highest quarterly Total Current Liabilities in data going back to Q4 2017.
  • On a year-over-year basis, Total Current Liabilities has increased for five consecutive quarters, with growth averaging 70.8% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 310.9% in Q2 2026, against a decline of 35.1% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $54.99 million (Q1 2026), $53.93 million (Q4 2025) and $37.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 137.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 137.15 Mn
Mar 31, 2026 54.99 Mn
Dec 31, 2025 53.93 Mn
Sep 30, 2025 37.80 Mn
Jun 30, 2025 33.38 Mn
Mar 31, 2025 25.55 Mn
Dec 31, 2024 22.23 Mn
Sep 30, 2024 25.56 Mn
Jun 30, 2024 27.29 Mn
Mar 31, 2024 31.48 Mn
Dec 31, 2023 27.27 Mn
Sep 30, 2023 39.41 Mn
Jun 30, 2023 34.74 Mn
Mar 31, 2023 28.76 Mn
Dec 31, 2022 32.90 Mn
Sep 30, 2022 23.38 Mn
Jun 30, 2022 20.00 Mn
Mar 31, 2022 16.00 Mn
Dec 31, 2021 16.67 Mn
Sep 30, 2021 14.60 Mn
API Access

BioXcel Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY